The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion-Reference-Cited by-同舟云学术

The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion

Published:2012-07-20 Issue:7 Volume:7 Page:e40378
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Fenouille Nina,Tichet Mélanie,Dufies Maeva,Pottier Anaïs,Mogha Ariane,Soo Julia K.,Rocchi Stéphane,Mallavialle Aude,Galibert Marie-Dominique,Khammari Amir,Lacour Jean-Philippe,Ballotti Robert,Deckert Marcel,Tartare-Deckert Sophie

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference54 articles.

1. Epithelial-mesenchymal transitions in development and disease.;JP Thiery;Cell,2009

2. SNAIL, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?;H Peinado;Nat Rev Cancer,2007

3. Malignant melanoma: genetics and therapeutics in the genomic era.;L Chin;Genes Dev,2006

4. Cadherins in neural crest cell development and transformation.;P Pla;J Cell Physiol,2001

5. Melanoma.;AJ Miller;N Engl J Med,2006

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Epithelial-to-Mesenchymal Transition Supports HCMV Infection and Biosynthesis in Mammary Epithelial Cells Through Two Distinct Mechanisms;2024-08-12

2. High charge of cerebroid nests in nodular melanomas predicts tumor aggressiveness and high mutational tumoral burden: a pilot study;Frontiers in Oncology;2024-07-19

3. High Serum Levels of CCL20 Are Associated with Recurrence and Unfavorable Overall Survival in Advanced Melanoma Patients Receiving Immunotherapy;Cancers;2024-04-29

4. K-Ras(V12) differentially affects the three Akt isoforms in lung and pancreatic carcinoma cells and upregulates E-cadherin and NCAM via Akt3;Cell Communication and Signaling;2024-01-30

5. FUT4 promotes the progression of Cholangiocarcinoma by modulating epithelial-mesenchymal transition;Cell Cycle;2024-01-17